These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11371899)

  • 1. Acute renal failure associated with sulfur calculi.
    Saito M; Takahashi C; Ishida G; Kadowaki H; Hirakawa S; Miyagawa I
    J Urol; 2001 Jun; 165(6 Pt 1):1985-6. PubMed ID: 11371899
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury.
    Durando M; Tiu H; Kim JS
    Am J Kidney Dis; 2017 Dec; 70(6):869-873. PubMed ID: 28669550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs as risk factor for renal failure from acute uric acid nephropathy.
    Albertazzi A; Cappelli P; Di Paolo B
    Nephron; 1987; 46(1):98. PubMed ID: 3600919
    [No Abstract]   [Full Text] [Related]  

  • 4. Cases from the Osler Medical Service at Johns Hopkins University.
    Prutkin J; Zaas D
    Am J Med; 2003 Jun; 114(8):702-5. PubMed ID: 12798463
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis.
    Molnár T; Farkas K; Nagy F; Iványi B; Wittmann T
    Inflamm Bowel Dis; 2010 Apr; 16(4):552-3. PubMed ID: 19637363
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].
    Son CN; Lee HL; Joo YW; Lee OY; Han DS; Yoon BC; Choi HS; Hahm JS
    Korean J Gastroenterol; 2008 Sep; 52(3):192-5. PubMed ID: 19077517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of ulcerative colitis with folate deficient megaloblastic anemia induced by sulfasalazine].
    Hoshino J; Sugawara K; Ishikawa S; Hayami Y; Sakurazawa T; Tanaka T; Yamamoto N; Hashimoto M; Yamamoto T; Hoshihara Y
    Nihon Shokakibyo Gakkai Zasshi; 1999 Jul; 96(7):840-5. PubMed ID: 10434561
    [No Abstract]   [Full Text] [Related]  

  • 9. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine].
    Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S
    Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune complex haemolytic anaemia associated with sulfasalazine.
    Teplitsky V; Virag I; Halabe A
    BMJ; 2000 Apr; 320(7242):1113. PubMed ID: 10775222
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
    Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
    Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J
    Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-induced lymphadenitis].
    Yin WH; Zhang HY; Li XF; Ma Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):192-4. PubMed ID: 20450768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 15. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
    Kao J; Kwok K; Das KM
    J Clin Gastroenterol; 2010 Sep; 44(8):531-5. PubMed ID: 20495466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive nephropathy secondary to sulfasalazine calculi.
    Russinko PJ; Agarwal S; Choi MJ; Kelty PJ
    Urology; 2003 Oct; 62(4):748. PubMed ID: 14550462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.
    Rosenbaum J; Alex G; Roberts H; Orchard D
    J Paediatr Child Health; 2010 Apr; 46(4):193-6. PubMed ID: 20546480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral obstructing renal stones: an uncommon cause of acute renal failure.
    Stone JR; Knutson TL; Kang C
    Am J Emerg Med; 2010 Mar; 28(3):390.e5-6. PubMed ID: 20223414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
    Gan HT; Chen YQ; Ouyang Q
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.